Pfizer (NYSE:PFE) (NYSE:PFE) is a global biopharmaceutical company that discovers, develops, manufactures and commercializes prescription medicines and vaccines. Its research and commercial activities focus on areas including oncology, inflammation and immunology, internal medicine, hospital care and vaccines.
The company’s portfolio includes widely used products such as the Prevnar family of pneumococcal vaccines, Ibrance for certain breast cancers, Eliquis for preventing blood clots, Xeljanz for inflammatory conditions, and Vyndaqel for transthyretin amyloidosis. Pfizer also developed Comirnaty, an mRNA COVID-19 vaccine, in partnership with BioNTech, and Paxlovid, an oral antiviral treatment for COVID-19.
Pfizer was founded in 1849 by Charles Pfizer and Charles Erhart in Brooklyn, New York. The company has expanded through internal research, licensing agreements and acquisitions, and serves patients and healthcare providers in markets around the world. Its operations include research and development, manufacturing and commercial activities across North America, Europe, emerging markets and other international regions.
Albert Bourla has served as Pfizer’s chief executive officer since 2019 and as chairman since 2020. The company continues to invest in its pipeline of medicines and vaccines, with research programs spanning oncology, rare diseases, infectious diseases and other areas of significant unmet medical need.
